JSC PHARMSTANDARD

Company Snapshot

Founded: 2003
Entity Type: Private
Region: Russia
Headquarter: Dolgoprudny, Moscow, Russia
Key Geographics: Russia
Corporate Address: 5B Likhachevsky proezd, Dolgoprudny Moscow Region 141701 Russia Tel. +7-495-970-0030 www.pharmstd.com

Company Overview

JSC Pharmstandard is Russia’s leading pharmaceutical company. It ranks second in the top 10 pharmaceutical companies operating in Russia. The company develops and manufactures high-quality pharmaceutical products that meet the requirements of the Russian healthcare system. It has entered collaborations with a number of U.S. and European pharmaceutical companies. JSC Pharmstandard operates large CMO facilities that are EC cGMP approved. It is working to establish U.S. FDA approval for cGMP manufacturing.

JSC Pharmstandard, along with Russian oligarch and billionaire Roman Abramovich’s investment company Millhouse, purchased the Russian biosimilars developer Biocad for an undisclosed sum in 2014.

JSC PHARMSTANDARD In Reports

Biologic Therapeutic Drugs: Technologies and Global Markets

BCC Research Market Analyst says global market for biological therapeutic drugs is expected to increase from $452.9 billion in 2023 to $823.4 billion by the end of 2028 with a CAGR of 12.7%.

Biologic Therapeutic Drugs: Technologies and Global Markets

Global market for biologic therapeutic drugs should increase from $285.5 billion in 2020 to reach $421.8 billion by 2025, at a CAGR of 8.1% during the forecast period of 2020-2025.

Company's Business Segments

  • Medicines Manufacturing : This segment engaged in the Development, Production of modern, high-quality, affordable medicines.

Applications/End User Industries

  • Healthcare
  • Pharmaceuticals
  • Clinics
  • Biotechnology
AI Sentiment